Experimental Parasitology 131 (2012) 130–132
Contents lists available at SciVerse ScienceDirect
Experimental Parasitology
journal homepage: www.elsevier.com/locate/yexpr
Research Brief
Anti-Trypanosoma cruzi and cytotoxic activities of Eugenia uniflora L.
Karla K.A. Santos a, Edinardo F.F. Matias a, Saulo R. Tintino a, Celestina E.S. Souza a, Maria F.B.M. Braga a,
Gláucia M.M. Guedes a, Miriam Rolón b, Celeste Vega b, Antonieta Rojas de Arias b, José G.M. Costa c,
Irwin R.A. Menezes d, Henrique D.M. Coutinho a,⇑
a
Laboratório de Microbiologia e Biologia Molecular, Universidade Regional do Cariri, Crato (CE), Brazil
Centro para el Desarrollo de la Investigación Científica (CEDIC), Fundación Moisés Bertoni/Laboratorios Díaz Gill, Asunción, Paraguay
Laboratório de Pesquisa em Produtos Naturais, Universidade Regional do Cariri, Crato (CE), Brazil
d
Laboratório de Farmacologia e Química Medicinal, Universidade Regional do Cariri, Crato (CE), Brazil
b
c
a r t i c l e
i n f o
Article history:
Received 17 May 2011
Received in revised form 20 February 2012
Accepted 21 February 2012
Available online 7 March 2012
Keywords:
Chagas disease
Eugenia uniflora
Antiepimastigote activity
Cytotoxicity
Trypanosoma cruzi
a b s t r a c t
Chagas disease is caused by Trypanosoma cruzi, being considered a public health problem. An alternative
to combat this pathogen is the use of natural products isolated from fruits such as Eugenia uniflora, a plant
used by traditional communities as food and medicine due to its antimicrobial and biological activities.
Ethanolic extract from E. uniflora was used to evaluate in vitro anti-epimastigote and cytotoxic activity.
This is the first record of anti-Trypanosoma activity of E. uniflora, demonstrating that a concentration presenting 50% of activity (EC50) was 62.76 lg/mL. Minimum inhibitory concentration (MIC) was 61024 lg/
mL. Our results indicate that E. uniflora could be a source of plant-derived natural products with anti-epimastigote activity with low toxicity.
Ó 2012 Elsevier Inc. All rights reserved.
1. Introduction
Developing countries with traditional use of the biodiversity as
medicine, including Brazil, still suffer with the so-called ‘‘neglected
diseases’’ (Funari and Ferro, 2005), which are treated by traditional
communities with plant natural products. Brazil features the largest biodiversity in the world (Elisabetsky and Costa-Campos,
1996); however only 8% have been studied in search for bioactive
compounds (Garcia et al., 1996).
Chagas disease, caused by Trypanosoma cruzi, affects about 18
million people in the Americas (Reyes-Chilpa et al., 2008). This parasite can be transmitted to humans by triatomine insects, foods,
blood and organs from infected donors, or by transplacental contamination (WHO, 2010). Currently, the chemotherapy of this disease consists mainly of nifurtimox and benzonidazole (WHO,
2010), which show a cure rate of 70–50% in the acute phase and
less than 20% in the chronic phase (Dias and Dessoy, 2009). Several
studies involving the analysis of natural plant products have
⇑ Corresponding author. Address: Laboratório de Microbiologia e Biologia
Molecular – LMBM, Departamento de Química Biológica – DQB, Universidade
Regional do Cariri – URCA, Rua Cel. Antonio Luis 1161, Pimenta 63105-000, Crato
(CE), Brazil. Fax: +55 (88) 31021291.
E-mail address: hdmcoutinho@gmail.com (H.D.M. Coutinho).
0014-4894/$ - see front matter Ó 2012 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.exppara.2012.02.019
recommended them as alternative sources of drugs against T. cruzi,
including Arrabidaea triplinervia (Leite et al., 2006), Dracocephalum
kotschyi (Saeidnia et al., 2004) and Azorella compacta (Araya et al.,
2003).
The effects of all natural products can be limited by their toxicity. Evaluating the toxicity of active substances is one of the
most important steps for the utilization of these compounds in
animal models. The drugs currently utilized against Chagas disease feature high toxicity, affecting host tissues (Dias and Dessoy,
2009).
Eugenia uniflora is often used as food and medicine in folk medicine due to antimicrobial (Holetz et al., 2002) and other biological
activities (Sharma et al., 2006). Known in Brazil as pitanga, this
plant has been studied due to its antioxidant (Velazquez et al.,
2003), hypotensive (Consolini and Sarubbio, 2002), photosensitizing and antibiotic modulatory (Coutinho et al., 2010a,b) activities.
Several phytoconstituents of E. uniflora have been isolated, such as
flavonoids myricitrin, quercetin and quercitrin 3-ramnoside, as
well as steroids, mono- and triterpenoid compounds, tannins,
anthraquinones, phenols, cineol and essential oils (Bandoni et al.,
1972; Wazlawik et al., 1997).
Thus, due to the social and economic importance of Chagas disease as neglected diseases and the medicinal use of this fruit in
ethnomedicine, this work evaluated the anti-Trypanosoma and
cytotoxic activities of E. uniflora.
131
K.K.A. Santos et al. / Experimental Parasitology 131 (2012) 130–132
2. Materials and methods
2.1. Plant material
Leaves of E. uniflora were collected during the rainy season
(April, 2008) in the municipality of Crato, Ceará State, Brazil. The
plant material was identified by Dr. Arlene Pessoa, and a voucher
specimen was deposited with identification number #3106 at the
‘‘Dárdano de Andrade Lima’’ Herbarium of Universidade Regional
do Cariri – URCA.
2.2. Preparation of E. uniflora ethanol extract (EEEU)
A total of 200 g of leaves were dried and powdered at room
temperature. The powdered material was extracted by maceration
using 1 L of 95% ethanol as solvent at room temperature. The mixture was allowed to stand for 72 h at room temperature. The extract was then filtered and concentrated under vacuum in a
rotary evaporator (60 °C and 760 mm/Hg of temperature and pressure) (Brasileiro et al., 2006). Each 200 g of aerial parts yield 5.6 g
of extract. The EEEU was diluted using DMSO.
Table 1
Percent parasite lysis induced by extracts of Eugenia uniflora against the epimastigote
form of Trypanosoma cruzi CL-B5 strain.
Extract
Concentrations
(lg/mL)
%AE
%SD
%C
EC50
EEEU
100
10
1
80.83
64.80
27.29
0.1
3.6
7.3
8
0
0
62.76
10
1
0.5
89.1
54.9
45.6
3.3
0.7
4.2
–
–
–
0.91
Nifurtimox
%AE – percentual of antiepimastigote activity; %SD – standard deviation; %C –
cytotoxic percentual; EC50 – concentration that present 50% of effect.
0.1 and 50 lg/mL, at 28 °C for 72 h, at which time 50 lL of CPRG
solution was added to reach a final concentration of 200 lM. The
plates were incubated at 37 °C for 6 h and were evaluated using
a spectrophotometer at 595 nm. Nifurtimox was used as the reference drug. Each concentration was tested in triplicate. Each experiment was performed twice separately. The efficacy of each
compound was estimated by calculating the anti-epimastigote percentage (AE%) (Table 1).
2.3. Cell strains
2.6. Cytotoxicity assays
For in vitro studies of anti-Trypanosoma activity, epimastigote
clone CL-B5 was used (Buckner et al., 1996). The parasites transfected with the Escherichia coli b-galactosidase gene (lacZ), were
kindly provided by Dr. F. Buckner through Instituto Conmemorativo Gorgas (Panama). The epimastigotes were cultivated at 28 °C
in Liver Infusion Tryptose Broth (Difco, Detroit, MI), supplemented
with 10% fetal bovine serum (FBS) (Gibco, Carlsbad, CA), penicillin
(Ern, S.A., Barcelona, Spain) and streptomycin (Reig Jofré S.A.,
Barcelona, Spain), as described by Le Senne et al. (2002). Cells were
harvested during the exponential growth phase. Murine J774 macrophages were used to evaluate the cytotoxic potential of the extract. This cell strain was grown in plastic 25 lL flasks with RPMI
1640 medium (Sigma) supplemented with 20% fetal bovine serum
(FBS), heat inactivated (30 min, 56 °C), penicillin G (100 U/mL) and
streptomycin (100 lg/mL) in a humidified, with 5% CO2/95% air
atmosphere at 37 °C. For the assay, cells in the pre-confluence
phase were harvested with trypsin and kept at 37 °C in a humidified 5% CO2 atmosphere. The cell viability measurement was a colorimetric method using resazurin as described by Rolón et al.
(2006).
J774 macrophages were seeded (5 104 cells/well) in 96-well
flat-bottom microplates with 100 lL of RPMI 1640 medium. The
cells were allowed to attach for 24 h in a humidified, with 5%
CO2/95% air atmosphere at 37 °C. The medium was replaced by
200 lL of medium with different concentrations of the drugs and
exposed for another 24 h. Growth controls were also included.
Next, 20 lL of resazurin solution with 2 mM were added and the
plates were returned to the incubator for another 3 h. Resazurin
reduction was determined by dual wavelength absorbance measurements at 490 and 595 nm, respectively. Each concentration
was assayed three times. Medium and drug controls were used
in each test. The cytotoxicity of each compound was estimated
by calculating the cytotoxic percentage (C%) (Table 1).
2.7. Statistical analysis
The EC50 values (concentration of extract needed to necessary
for produce of 50% maximal effect) were determined by linear
regression analysis of the using Prism Software 5.0.
2.4. Reagents
3. Results and discussion
Resazurin sodium salt was obtained from Sigma–Aldrich (St.
Louis, MO, USA) and stored at 4 °C protected from light. The resazurin solution was prepared using 1% phosphate buffered solution
(PBS), pH 7, and sterilized by filtration prior to use. Chlorophenol
red-b-D-galactopyranoside (CPRG; Roche, Indianapolis, IN, USA)
was dissolved in 0.9% Triton X – 100 (pH 7.4). The solutions of antibiotics penicillin G (Ern, S.A., Barcelona, Spain), streptomycin (Reig
Jofré S.A., Barcelona, Spain) were prepared following the recommendations of the National Committee for Clinical Laboratory
Standards – NCCLS (NCCLS, 2003).
3.1. Anti-epimastigote assay
2.5. Epimastigote susceptibility assay
The screening assay was performed in 96-well microplates with
cultures that had not reached the stationary phase, as described by
Vega et al. (2005). Briefly, epimastigotes were seeded at
1 105 mL 1 in 200 lL of Liver Tryptose Broth medium. The plates
were incubated with the drugs in concentrations ranging between
The anti-epimastigote activity of EEEU is shown in Table 1. The
results showed 80% inhibition with a concentration of 100 lg/mL,
featuring EC50 = 62.76 lg/mL, which was quite impressive due the
fact that EC50 lower than 500 lg/mL is considered clinically relevant (Rosas et al., 2007).
This is the first report of anti-Trypanosoma activity for E. uniflora. This activity was previously reported for the family Myrtaceae.
Siphoneugena densiflora showed a strong effect against T. cruzi;
however, its isolated compounds did not show similar activity
(Gallo et al., 2008). Other plants of the Brazilian flora have shown
substantial trypanocidal activity, such as Ampelozizyphus amazonicus, a plant native to the Amazon forest, containing compounds
with potential for use as a prophylactic agent against that parasite
(Rosas et al., 2007). The ethyl acetate fraction of the aqueous extract of Camellia sinensis leaves and the principal components of
this fraction (catechins) demonstrated anti-trypo and amastigote
132
K.K.A. Santos et al. / Experimental Parasitology 131 (2012) 130–132
forms (Paveto et al., 2004). Trypanocidal activity has also been reported for Dracocephalum komarovi (Saeidnia et al., 2004), Vitex trifolia L. (Kiuchi et al., 2004), A. triplinervia (Leite et al., 2006) and A.
compacta (Araya et al., 2003).
3.2. Cytotoxic activity
The cytotoxic activity of natural products against mammalian
cells is an important point in the search for active compounds with
biological activity. The results of cytotoxic activity of EEEU against
J774 macrophages are presented in Table 1. A low toxicity was observed (8% to 100 lg/mL, and this toxicity was reduced to 0% with
a concentration of 10 lg/mL). This low toxicity associated with trypanocidal and modulatory activity indicates that new assays need to
be carried out in vivo to demonstrate the real potential of the EEEU
against these pathogens and its effective nutraceutical potential.
The evaluation of cytotoxic activity of natural products could be
demonstrated by the numerous reports using different cell models:
Calophyllum brasiliense, tested with human lymphocytes (ReyesChilpa et al., 2008); Capparis spinosa, Kleinia odora and Psiadia
punctulata, assayed with MRC-5 cells (Abdel-Sattar et al., 2010);
and neolignans, such as licarin A and burchellin, evaluated against
peritoneal macrophages (Cabral et al., 2010). The ethanol extract of
E. uniflora appears to be promising in the development of more
effective therapies, mainly due to the low level of toxicity
in vitro, which allows us to proceed with in vivo studies for drug
evaluation.
4. Conclusion
Our results indicate that E. uniflora (and the family Myrtaceae in
general) could be a source of nutraceuticals with anti-Trypanosoma
activity, representing an interesting alternative to combat infectious diseases as Chagas disease. This plant appears to be promising in the development of therapies, mainly due the low toxicity
in vitro, which allows us to proceed with in vivo studies for drug
evaluation.
Acknowledgments
The authors are grateful to the Brazilian research agencies CNPq
and FUNCAP.
References
Abdel-Sattar, E., Maes, L., Salama, M.M., 2010. In vitro activities of plant extracts
from Saudi Arabia against Malaria, Leishmaniasis, Sleeping Sickness and Chagas
Disease. Phytotherapy Research 24, 1–9.
Araya, J.E., Neira, I., Silva, S., Mortara, R.A., Manque, P., 2003. Diterpenoids from
Azorella compacta (Umbelliferae) active on Trypanosoma cruzi. Memórias do
Instituto Oswaldo Cruz 98, 413–418.
Bandoni, A.L., Mendiondo, M.E., Rondina, R.V.D., Coussio, J.D., 1972. Survey of
Argentine medicinal plants. I. Folklore and phytochemical screening. Lloydia 35,
69–80.
Brasileiro, B.G., Pizziolo, V.R., Raslan, D.S., Jamal, C.M., Silveira, D., 2006.
Antimicrobial and cytotoxic activities screening of some Brazilian medicinal
plants used in Governador Valadares district. Brazilian Journal of
Pharmaceutical Science 42, 195–202.
Buckner, F.S., Verlinde, C.L., La Flamme, A.C., Van Voorhis, W.C., 1996. Efficient
technique for screening drugs for activity against Trypanosoma cruzi using
parasites
expressing
beta-galactosidase.
Antimicrobial
Agents
and
Chemotherapy 40, 2592–2597.
Cabral, M.M.O., Barbosa-Filho, J.M., Maia, G.L.A., Chaves, M.C.O., Braga, M.V., 2010.
Neoglicans from plants in northeastern Brazil (Lauraceae) with activity against
Trypanosoma cruzi. Experimental Parasitology 124, 319–324.
Consolini, A.E., Sarubbio, M.G., 2002. Pharmacological effects of Eugenia uniflora
(Myrtaceae) aqueous crude extract on rat’s heart. Journal of
Ethnopharmacology 81, 57–63.
Coutinho, H.D.M., Costa, J.G.M., Falcão-Silva, V.S., Siqueira-JR, J.P., Lima, E.O., 2010a.
Potentiation of antibiotic activity by Eugenia uniflora and Eugenia jambolanum.
Journal of Medicinal Food 13, 1024–1026.
Coutinho, H.D.M., Costa, J.G.M., Siqueira-JR, J.P., Lima, E.O., 2010b. In vitro screening
by phototoxic properties of Eugenia uniflora L., Momordica charantia L., Mentha
arvensis L. and Turnera ulmifolia L. Brazilian Journal of Bioscience 8, 299–
301.
Dias, L.C., Dessoy, M.A., 2009. Chemotherapy of Chagas’ disease: state of the art and
perspectives for the development of new drugs. Quimica Nova 32, 2444–2457.
Elisabetsky, E., Costa-Campos, L., 1996. Medicinal plant genetic resources and
international
cooperation:
the
Brazilian
perspective.
Journal
of
Ethnopharmacology 51, 110–120.
Funari, C.S., Ferro, V.O., 2005. Uso ético da biodiversidade brasileira: necessidade e
oportunidade. Revista Brasileira de Farmacognosia 15, 178–182.
Gallo, M.B.C., Marques, A.S.F., Vieira, P.C., Silva, M.F.G.D., Fernandes, J.B., 2008.
Enzymatic Inhibitory activity and trypanocidal effects of extracts and
compounds from Siphoneugena densiflora O. Berg and Vitex polygama Cham.
Zeitschrift Naturforschung C 63, 371–382.
Garcia, E.S., Silva, A.C.P., Gilbert, B., Corrêa, C.B.V., Cavalheiro, M.V.S., Santos, R.R.,
1996. Fitoterápicos. In: Farmacognosia: da planta ao medicamento. fourth ed.,
Campinas, Editora da UFSC.
Holetz, F.B., Pessini, G.L., Sanches, N.R., Cortez, D.A., Nakamura, C.V., 2002. Screening
of some plants used in the Brazilian folk medicine for the treatment of
infectious diseases. Memórias do Instituto Oswaldo Cruz. 97, 1027–1031.
Kiuchi, F., Matsio, K., Ito, M., Qui, T.K., Honda, G., 2004. New norditerpenoids with
Trypanocidal activity from Vitex trifolia. Chemical and Pharmaceutical Bulletin
52, 1492–1494.
Leite, J.P.V., Oliveira, A.B., Lombardi, J.A., Filho, J.D.S., Chiari, E., 2006. Trypanocidal
activity of Triterpenes from Arrabidaea triplinervia and derivates. Biological and
Pharmaceutical Bulletin 29, 2307–2309.
Le Senne, A., Muelas-Serrano, S., Fernandez-Portillo, C., Escario, J.Á., Gómez-Barrio,
A., 2002. Biological characterization of a beta-galactosidase expressing clone of
Trypanosoma cruzi CL strain. Memórias do Instituto Oswaldo Cruz. 97, 1101–
1105.
NCCLS – National committee for clinical laboratory standards, 2003. Performance
standards of antimicrobial disk susceptibility test. NIH, Atlanta.
Paveto, C., Güida, M.C., Esteva, M.I., Martino, V., Coussio, J., Flawiá, M.M., 2004. AntiTrypanosoma cruzi activity of green tea (Camellia sinensis) catechins.
Antimicrobial Agents and Chemotherapy 48, 69–79.
Reyes-Chilpa, R., Estrada-Muñiz, E., Veja-Avila, E., Abe, F., Kinjo, J., HérnandezOrtega, S., 2008. Trypanocidal constituents in plants Mammea-type coumarins.
Memórias do Instituto Oswaldo Cruz 103, 431–436.
Rolón, M., Seco, E., Veja, C., Nogal, J.J., Escario, J.A., Gómez-Barrio, A., 2006. Selective
activity of polyene macrolides produced by genetically modified Streptomyces
on Trypanosoma cruzi. International Journal of Antimicrobial Agents 28, 104–
109.
Rosas, L.V., Cordeiro, M.S.C., Campos, F.R., Nascimento, S.K.R., Januário, A.H., França,
S.C., 2007. In vitro evaluation of the cytotoxic and trypanocidal activities of
Ampelozizyphus amazonicus (Rhamnaceae). Brazilian Journal of Medical and
Biological Research 40, 663–670.
Saeidnia, S., Gohari, A.R., Uchiyama, N., Ito, M., Honda, G., Kiuchi, F., 2004. Two new
monoterpene glycosides and trypanocidal terpenoids from Dracocephalum
kotschyi. Biological and Pharmaceutical Bulletin 52, 1249–1250.
Sharma, S.B., Nasir, A., Prabhu, K.M., Murthy, P.S., 2006. Antihyperglycemic effect of
the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus. Journal of
Ethnopharmacology 104, 367–373.
Vega, C., Rolón, M., Martínez-Fernández, A.R., Escario, J.Á., Gómez-Barrio, A., 2005. A
new pharmacological screening assay with Trypanosoma cruzi epimastigotas
expressing beta-galactosidase. Parasitology Research 95, 296–298.
Velazquez, E., Tournier, H.A., Mordujovich de Buschiazzo, P., Saavedra, G., Schinella,
G.R., 2003. Antioxidant activity of Paraguayan plant extracts. Fitoterapia 74, 91–
97.
Wazlawik, E., Da Silva, M.A., Peters, R.R., Correia, J.F., Farias, M.R., Calixto, J.B., 1997.
Analysis of the role of nitric oxide in the relaxant effect of the crude extract and
fractions from Eugenia uniflora in the rat thoracic aorta. Journal of Pharmacy and
Pharmacology 49, 433–437.
WHO – World Health Organ fact sheet No. 340, 2010. Chagas disease (American
trypanosomiasis). Available in: <http://www.who.int/mediacentre/factsheets/
fs340/en/> (accessed 10.09.10).